PCI Biotech (OSE: PCIB), today announces its preliminary full year 2024 results. Please find enclosed the interim report and presentation. Highlights review OperationsPCI ...
PCI Biotech's 2024 development goals were to demonstrate scalability and manufacturing process benefits of the ...
The funding comes as Eikon, run by former Merck research chief Roger Perlmutter, has started a Phase 3 trial testing one of ...
Q4 2024 Earnings Call Transcript March 3, 2025 Fortrea Holdings Inc. misses on earnings expectations. Reported EPS is $0.18 ...
Presentation Date / Time: Saturday, March 8, 2025; 1 p.m. PST ...
THIRUVANANTHAPURAM: The National Science Day celebrations in the state on Friday were marked by a unique presentation of new ...
The biotech industry thrives on innovation, but conveying complex ideas to diverse audiences requires specialized expertise.
Registration Link for Presentation and live Q&A to take place, Wednesday March 5, 2025 at 12:00 pm EST Marlborough, ...
Q4 2024 Earnings Call Transcript February 28, 2025 Operator: Thank you for standing by, and good day, everyone. My name is RG ...
Astellas Pharma U.S. Inc. (Head of Commercial: Mike Petroutsas, "Astellas"), and MBC BioLabs, a premier launchpad for early-stage life-science companies, today announced their collaboration on the ...
PITTSBURGH, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company ... A webcast of the presentation will be available here beginning at 1:50 pm ET on Tuesday, March 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback